Latest filing published 13 Nov 2007 for Perspective Therapeutics, Inc., €1,659.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -88.9%Entry US$22.60 · Close at T+365 US$2.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Roger Girard: trading record in brief
Roger Girard discloses dealings in Perspective Therapeutics, Inc. to SEC (Form 4). The record holds 3 filings, for trades running from 8 August 2006 to 12 November 2007.
Purchases make up the whole of the open-market record (2 purchases, €4,138). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. 2007 to date brings 2 purchases and no sales.
The latest filing, published on 13 November 2007, reports an open-market purchase of €1,659 in Perspective Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Roger Girard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$2.41common stockSEC:0001342647-07-000017:0Canonical exit: 10 Feb 2008 (T+90)
- 1,500 shares@ US$2.40common stockSEC:0001342647-07-000017:1Canonical exit: 10 Feb 2008 (T+90)
- 30,072 sharescommon stockSEC:0001342647-06-000016:0
3 of 3 declarations